Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis. - Wikidata - wikimedia - TriplyDB

Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.

Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.

http://www.wikidata.org/entity/Q37070721

about

Recent advances in the molecular diagnostics of gastric cancer Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction.Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.Increased microRNA-630 expression in gastric cancer is associated with poor overall survival.Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction.Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review).Prognostic value of miR-96 in patients with acute myeloid leukemia.Cancer development, progression, and therapy: an epigenetic overview.MicroRNA and signaling pathways in gastric cancer.The p53/microRNA connection in gastrointestinal cancer.MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1.Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis.Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer.Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma.Prognostic value of microRNAs in gastric cancer: a meta-analysis Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.NTRK2 is an oncogene and associated with microRNA-22 regulation in human gastric cancer cell lines.Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancer pathogenesis.Evaluation of altered expression of miR-9 and miR-106a as an early diagnostic approach in gastric cancer.Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis.Effects of miR-22 on viability, migration, invasion and apoptosis in retinoblastoma Y79 cells by targeting high-mobility group box 1

P2860

Q26785548-3244C799-D5DB-4F3A-9CE2-4A27E1EE8B6D Q33847328-FA9284B7-FC4C-4EF0-84E1-AF544955635D Q34268397-E28ABCC5-13EF-4231-B274-690B791DBED8 Q34485283-4D1D7C02-0EF4-4A5C-91B9-C90B78DF78F3 Q35118872-C9B3A00C-B9C6-4564-99D3-A8121DC0432D Q35694667-DB4A7BB3-8601-4A55-9851-9105D41AFF0C Q37588086-931D08F0-23B3-4FAC-BC04-1C881173A3C7 Q37683832-C34ECDC9-AB96-4D8E-ADF4-C6D33A2B5C07 Q38154977-FBA3DE06-F60F-4B3D-B5EE-C5B032AC8E60 Q38233783-115E8AF6-1C19-49D0-B760-3BC779EABE09 Q38261312-648D5D4C-902E-42B6-AD51-90EEFAE5A32F Q38638014-EE0B2C7C-7B0B-4BE4-B920-9D285AB64384 Q39237748-5ACB1F00-96E0-49BF-9388-084AC64226D7 Q39321339-26FD9F4D-FD77-4A2E-9715-C86500974CA9 Q41471256-3643CBD8-A03A-415B-9655-5BF2803BF8B5 Q41530973-7361371E-F366-45C4-B892-19A3903FBD8D Q41548169-9024B6D3-ED37-4A9F-B53D-E03F383EF673 Q41753919-87C580F5-A5A8-4187-8884-C8B013C3D027 Q51469478-B530D531-DC38-4D5F-9148-C2EB3D64002A Q51790481-E2B488DE-E50C-4509-B1A7-06F45B20DBC4 Q53176896-D629E624-ED78-4B2D-B894-71692A8FF773 Q54994542-89EF0B47-44AE-43D7-990A-1984B2D7AA87 Q58597272-9D5725EB-88A0-48B6-ACD5-73397C5AA821

P2860

Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.

http://www.wikidata.org/entity/Q37070721

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reduced expression of miR-22 i ...... eristics or patient prognosis.

@en

Reduced expression of miR-22 i ...... eristics or patient prognosis.

@nl

type

label

Reduced expression of miR-22 i ...... eristics or patient prognosis.

@en

Reduced expression of miR-22 i ...... eristics or patient prognosis.

@nl

prefLabel

Reduced expression of miR-22 i ...... eristics or patient prognosis.

@en

Reduced expression of miR-22 i ...... eristics or patient prognosis.

@nl

P1433

Q37070721-6C7C5D46-0A47-487C-9042-76DFB8AF67E8

P1476

Q37070721-E3EA507D-FF61-4400-8450-35E427062F62

P2093

Q37070721-6CB1025A-1FE7-4FF6-937C-FF3E39CE2F43

Q37070721-712BB477-86F1-45AE-AA17-1CB9E9A6DF4E

Q37070721-B5C5F955-4EFA-4C9B-A009-54034736D6AD

Q37070721-C6BA3D49-0452-4A31-A9E0-0EAF0E7BD25C

Q37070721-E050642F-FA7C-4B1C-B01A-C67F185B4DDE

Q37070721-E2672BE5-8BC5-4E0F-B00E-4FABC72D3C17

P2860

Q37070721-07B69454-18C6-4C12-AD4B-266FDE80B164

Q37070721-1141B8F7-9882-4FBB-A813-906F1397BF35

Q37070721-1449E5A1-7AD3-4F8B-A29A-FC6319605843

Q37070721-14C9FE96-1712-4AA1-8FB2-188605B40CEC

Q37070721-1541D738-C7AB-47F2-A3A6-605B6E128826

Q37070721-20FBB656-A91B-4963-B637-6583D441BB60

Q37070721-2282AAD1-1BCB-4F44-ADEC-57A523EF5434

Q37070721-2726598B-A974-4CF5-80D8-3CD0A50A1C42

Q37070721-2F58E21E-E7CE-4FED-B982-05A56B709405

Q37070721-39C7F2A1-80D6-4F5F-BCDB-FCC99F1CD4CD

P2888

Q37070721-C77E5B5E-4B07-4B30-9E0E-17BD6FDB666B

P304

Q37070721-7515D9DB-F29E-474C-BD10-76619F804F8C

P31

Q37070721-F3D9C5EF-A49C-45AE-9348-45FED523709C

P356

Q37070721-8FE8DD20-51EC-409A-BFE6-A64FF158E10C

P478

Q37070721-6DD9D2F4-D8A5-4545-ADC0-A774C0BE7DD7

P577

Q37070721-07CC40D0-A468-47D5-864D-470622AE24E0

P5875

Q37070721-E0E193A7-97B6-421F-833E-AC95A025D40B

P6179

Q37070721-11E6B34E-D75D-4C30-93D2-ECAC31A070E9

P698

Q37070721-FE08FC49-54C2-4079-A3B2-E206C53BEB72

P921

Q37070721-F0497967-B0DF-452B-841B-51048353C3C0

P932

Q37070721-A0950209-1BB3-4080-A3BD-49FEE4D28320

P356

1746-1596-8-102

P1433

Diagnostic Pathology

P1476

Reduced expression of miR-22 i ...... eristics or patient prognosis.

@en

P2093

Fujun Li

http://www.w3.org/2001/XMLSchema#string

Qi Yang

http://www.w3.org/2001/XMLSchema#string

Weibin Wang

http://www.w3.org/2001/XMLSchema#string

Xingchun Gao

http://www.w3.org/2001/XMLSchema#string

Yanyang Tu

http://www.w3.org/2001/XMLSchema#string

Yong Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

Cancer statistics, 2013

Oncomirs - microRNAs with a role in cancer

Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks

Specificity of microRNA target selection in translational repression

An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples.

MicroRNA-22 regulates hypoxia signaling in colon cancer cells.

miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide.

Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression.

P2888

1746-1596-8-102

P304

102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1746-1596-8-102

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240308202

http://www.w3.org/2001/XMLSchema#string

P6179

1036602174

http://www.w3.org/2001/XMLSchema#string

P698

23786758

http://www.w3.org/2001/XMLSchema#string

P921

P932

3733645

http://www.w3.org/2001/XMLSchema#string